{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:01:37Z","timestamp":1760781697382},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.semnephrol.2011.11.009","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T22:23:37Z","timestamp":1330035817000},"page":"63-69","source":"Crossref","is-referenced-by-count":7,"title":["Role of Vitamin D Receptor Activators in Cardio-Renal Syndromes"],"prefix":"10.1016","volume":"32","author":[{"given":"Mario","family":"Cozzolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bruschetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Cusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2011.11.009_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003495-200767140-00002","article-title":"Vitamin D receptor activator selectivity in the treatment of the secondary hyperparathyroidism","volume":"67","author":"Brancaccio","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib2","article-title":"Mineral metabolism abnormalities and vitamin D receptor activation in cardio-renal syndromes","author":"Ronco","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.amjcard.2010.04.042","article-title":"Role of vitamin D in cardiovascular health","volume":"106","author":"Vanga","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib4","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrcardio.2009.135","article-title":"Vitamin D status and arterial hypertension: a systematic review","volume":"6","author":"Pilz","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11739-010-0407-4","article-title":"Vitamin D and health status in elderly","volume":"6","author":"Timpini","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12265-009-9111-z","article-title":"Does Vitamin D protect against cardiovascular disease?","volume":"2","author":"Shari","year":"2009","journal-title":"J Cardiovasc Trans Res"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsbmb.2006.07.004","article-title":"Differential effects of vitamin D analogs on calcium transport","volume":"103","author":"Nakane","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2005.07.007","article-title":"Differential effects of vitamin D analogs on bone formation and resorption","volume":"98","author":"Nakane","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000223801","article-title":"Importance of vitamin D receptor activation in clinical practice","volume":"163","author":"Cozzolino","year":"2009","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5414\/CNP71593","article-title":"Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the \u201cU\u201d","volume":"71","author":"Cozzolino","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1538-7836.2004.01038.x","article-title":"Production of plasminogen activator inhibitor 1 (PAI-1) by endothelial cells: differential responses to calcitriol and paricalcitol","volume":"2","author":"Petrie","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2011.11.009_bib13","first-page":"14","article-title":"Plasminogen activator inhibitor type 1 (PAI-1) and its role in cardiovascular disease","volume":"82","author":"Nordt","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib14","unstructured":"Mizobuchi M, Finch JL, Martin DR, et al. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int. [Epub Jun 2007]."},{"key":"10.1016\/j.semnephrol.2011.11.009_bib15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/ndt\/gfh123","article-title":"Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings","volume":"19","author":"Dobrez","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN20051544","article-title":"Putting cardiovascular disease and vitamin D insufficiency into perspective","volume":"94","author":"Zitterman","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib19","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","article-title":"Active serum vitamin D levels are inversely correlated with coronary calcification","volume":"96","author":"Watson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2006.02633.x","article-title":"Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients","volume":"65","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ije\/19.3.559","article-title":"Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study","volume":"19","author":"Scragg","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.STR.0000195184.24297.c1","article-title":"Reduced vitamin D in acute stroke","volume":"37","author":"Poole","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension","volume":"49","author":"Forman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib26","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Krause","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jc.86.4.1633","article-title":"Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women","volume":"86","author":"Pfeifer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.107.107821","article-title":"Dietary intake of diary products, calcium, and vitamin D and the risk of hypertension in middle aged and older women","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","article-title":"Vitamin D supplementation improves cytokine profiles in patients with congestive hearth failure: a double-blind, randomized, placebo-controlled trial","volume":"83","author":"Schleithoff","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib30","first-page":"313","article-title":"Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study","volume":"167","author":"Shea","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/95.12.787","article-title":"Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanism for inflammatory damage in chronic disorders?","volume":"95","author":"Timms","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib32","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1210\/jc.2003-030358","article-title":"Bone turnover in prolonged critical illness: effect of vitamin D","volume":"88","author":"Van den Berghe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib33","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.2337\/diacare.28.12.2926","article-title":"Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women","volume":"28","author":"Liu","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib34","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.2337\/dc07-0292","article-title":"Serum 25-hydroxyvitamin D concentrations and subsequent risk of type 2 diabetes","volume":"30","author":"Mattila","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000104875","article-title":"Differential inhibition of rennin mRNA expression by paricalcitol and calcitriol in C57\/BL6 mice","volume":"106","author":"Fryer","year":"2007","journal-title":"Nephrol Physiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/eje.0.1370495","article-title":"Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy","volume":"137","author":"Heikkinen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(89)91634-6","article-title":"Latitude and ischaemic heart disease","volume":"1","author":"Fleck","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S8756-3282(02)00692-0","article-title":"Serum 25-hydroxyvitamin D status f adolescent and adults in two seasonal subpopulations from NHANES III","volume":"30","author":"Looker","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib39","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0895-7061(95)00154-H","article-title":"Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men","volume":"8","author":"Lind","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","article-title":"Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease","volume":"99","author":"Perez-Castrillon","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s001250051112","article-title":"Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus","volume":"42","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","article-title":"Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor","volume":"17","author":"Zeitz","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paracalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL Study): a randomised controlled trial","volume":"376","author":"De Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/eurjhf\/hfq112","article-title":"The vitamin D system: a crosstalk between the heart and kidney","volume":"12","author":"Cozzolino","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib45","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200767140-00003","article-title":"Nonclassical aspects of differential vitamin D receptor activation","volume":"67","author":"Andress","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.mnh.0000168336.67499.c0","article-title":"Arterosclerosis, vascular calcifications and cardiovascular disease in uremia","volume":"14","author":"London","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2011.11.009_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2310\/6650.2006.05051","article-title":"Atherosclerosis: immune and inflammatory aspects","volume":"54","author":"Reiss","year":"2006","journal-title":"J Invest Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T05:30:33Z","timestamp":1561354233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929511001884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0270929511001884"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2011.11.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}